Revivicor

Revivicor is a biotechnology company that develops methods to modify animals, primarily pigs, to produce organs suitable for human transplantation. By using advanced genetic engineering, they remove or alter pig genes that could cause immune rejection in humans, aiming to create compatible donor organs. This approach has the potential to address organ shortages and save lives by providing more available and safer transplant options. Revivicor’s work is part of the growing field of xenotransplantation, which explores using animal organs to meet human medical needs.